PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
23259992-9	2013	In conclusion, these findings demonstrated that PepT1 had a major influence on the permeability of fMet-Leu-Phe in duodenum, jejunum, and ileum in wild-type mice and on inflammatory response in intestinal regions that expressed PepT1.	leucyl-phenylalanine	104-111	solute carrier family 15 (oligopeptide transporter), member 1	Mus musculus	48-53
18834877-4	2008	We demonstrate that catestatin dose-dependently stimulates chemotaxis of human peripheral blood monocytes, exhibiting its maximal effect at a concentration of 1 nM comparable to the established chemoattractant formylated peptide Met-Leu-Phe (fMLP).	leucyl-phenylalanine	233-240	chromogranin A	Homo sapiens	20-30
23259992-5	2013	Jejunal uptake of [(3)H]fMet-Leu-Phe was specific for PepT1 and saturable with an intrinsic K(0.5) of 1.6 mM.	leucyl-phenylalanine	29-36	solute carrier family 15 (oligopeptide transporter), member 1	Mus musculus	54-59
18367166-4	2008	PL3S significantly inhibited the generation of superoxide anion and the release of elastase in formyl-l-methionyl-l-leucyl-l-phenylalanine (FMLP)-activated human neutrophils in a concentration-dependent fashion with IC50 values of 3.06+/-0.20 and 3.30+/-0.48 microM, respectively.	leucyl-phenylalanine	114-138	formyl peptide receptor 1	Homo sapiens	140-144
10533848-4	1999	Addition of the chemotactic oligopeptide f-met-leu-phe (fMLP; 100 nM) induced a NO release which reached a value of 71 +/- 30 pmol NO/10(6) PMN x ml(-1) 5 min after stimulation in the presence of SOD (150 U/ml).	leucyl-phenylalanine	47-54	formyl peptide receptor 1	Homo sapiens	56-60
17154364-7	2007	Addition of a chemotactic peptide formyl Met-Leu-Phe (fMLP) also induced translocation of TRPV2-EGFP to the plasma membrane.	leucyl-phenylalanine	44-52	transient receptor potential cation channel, subfamily V, member 2	Mus musculus	90-95
11443050-5	2001	In contrast, selective depletion of PKC-beta in HL60 cells by an antisense strategy enhanced fMet-Leu-Phe-initiated Ca(2+) uptake but not mobilization of intracellular Ca(2+).	leucyl-phenylalanine	98-105	protein kinase C beta	Homo sapiens	36-44
10816567-4	2000	Stimulation of the cells with fMet-Leu-Phe or interleukin-8 increased the PI3K activity in p110gamma, but not p85, immunoprecipitates.	leucyl-phenylalanine	35-42	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	Homo sapiens	91-100
10816567-4	2000	Stimulation of the cells with fMet-Leu-Phe or interleukin-8 increased the PI3K activity in p110gamma, but not p85, immunoprecipitates.	leucyl-phenylalanine	35-42	phosphoinositide-3-kinase regulatory subunit 2	Homo sapiens	110-113
10533848-4	1999	Addition of the chemotactic oligopeptide f-met-leu-phe (fMLP; 100 nM) induced a NO release which reached a value of 71 +/- 30 pmol NO/10(6) PMN x ml(-1) 5 min after stimulation in the presence of SOD (150 U/ml).	leucyl-phenylalanine	47-54	superoxide dismutase 1	Homo sapiens	196-199
9178190-3	1997	Some hydroxychalcone derivatives showed strong inhibitory effects on the release of beta-glucuronidase and lysozyme, and on superoxide formation by rat neutrophils stimulated with the peptide fMet-Leu-Phe (fMLP).	leucyl-phenylalanine	197-204	glucuronidase, beta	Rattus norvegicus	84-102
9867877-7	1999	These data indicate that activation of p38 by fMet-Leu-Phe and lipopolysaccharide involve different mechanisms, and that activation of protein kinase G by NO-dependent stimulation of guanylyl cyclase is necessary and sufficient for phosphorylation of p38 downstream of lipopolysaccharide.	leucyl-phenylalanine	51-58	mitogen-activated protein kinase 14	Homo sapiens	39-42
9400833-3	1997	Their use allowed us to observe that Cbl was tyrosine phosphorylated in response to some (FcgammaRII ligation, opsonized bacteria and zymosan, granulocyte-macrophage colony-stimulating factor, monosodium urate, and calcium pyrophosphate microcrystals), but not all (fMet-Leu-Phe, interleukin-8) neutrophil agonists.	leucyl-phenylalanine	271-278	Cbl proto-oncogene	Homo sapiens	37-40
9346964-2	1997	Stimulation of the cells with the chemoattractant fMet-Leu-Phe or the chemokines IL-8 and GROalpha leads to the rapid and transient activation of PKB.	leucyl-phenylalanine	55-62	protein tyrosine kinase 2 beta	Homo sapiens	146-149
8645978-4	1996	The inflammatory mediators were analyzed after cellular activation with different stimuli: the Ca ionophore A23187, which bypasses membranous signal transduction elements; the bacterial peptide formyl-methionine-leucyl-phenylalanine (fMLP), which activates cells by binding to a GTP-protein (G-protein)-coupled receptor, and with sodium fluoride (NaF), which directly activates G-proteins.	leucyl-phenylalanine	212-232	formyl peptide receptor 1	Homo sapiens	234-238
2540256-1	1989	Both purified human monocyte interleukin-1 and recombinant interleukin-1 (beta) primed neutrophils for increased superoxide production and chemiluminescence in response to f-met-leu-phe.	leucyl-phenylalanine	178-185	interleukin 1 beta	Homo sapiens	59-79
8564710-1	1995	When granulocyte-macrophage colony-stimulating factor (GM-CSF)-treated human neutrophils were challenged with the chemotactic factor fMet-Leu-Phe, it was possible to detect a time-dependent increase in the hydrolytic (as measured by the production of phosphatidic acid, PA) and the transphosphatidylation (as measured by the production of phosphatidylethanol, PEt) activities of phospholipase D in intact cells prelabeled with a radioactive fatty acid.	leucyl-phenylalanine	138-145	colony stimulating factor 2	Homo sapiens	5-53
8564710-1	1995	When granulocyte-macrophage colony-stimulating factor (GM-CSF)-treated human neutrophils were challenged with the chemotactic factor fMet-Leu-Phe, it was possible to detect a time-dependent increase in the hydrolytic (as measured by the production of phosphatidic acid, PA) and the transphosphatidylation (as measured by the production of phosphatidylethanol, PEt) activities of phospholipase D in intact cells prelabeled with a radioactive fatty acid.	leucyl-phenylalanine	138-145	colony stimulating factor 2	Homo sapiens	55-61
7512725-11	1994	GM-CSF also potentiates greatly the fMet-Leu-Phe-induced tyrosine phosphorylation and activation of a mitogen-activated protein kinase and, since fMet-Leu-Phe causes an intracellular calcium rise, the amount of the phospholipase A2 that is associated with the membrane fraction.	leucyl-phenylalanine	41-48	colony stimulating factor 2	Homo sapiens	0-6
7512725-11	1994	GM-CSF also potentiates greatly the fMet-Leu-Phe-induced tyrosine phosphorylation and activation of a mitogen-activated protein kinase and, since fMet-Leu-Phe causes an intracellular calcium rise, the amount of the phospholipase A2 that is associated with the membrane fraction.	leucyl-phenylalanine	41-48	phospholipase A2 group IB	Homo sapiens	215-231
8336074-3	1993	Lung giant cell carcinoma-derived chemotactic protein (LUCT)/IL-8 and fMet-Leu-Phe stimulate phosphorylation of a 64-kd protein (p64) in 32P-labeled human polymorphonuclear leukocytes (PMNs).	leucyl-phenylalanine	75-82	interleukin 2 receptor subunit gamma	Homo sapiens	129-132
2328263-1	1990	The various diastereomers of the N alpha-formylated(CHO) and tert-butyloxycarbonylated (t-Boc) Phe-(Leu-Phe)n and (Leu-Phe)n methyl esters, where n = 1-2 and 1-3, respectively, have been newly synthesized and their physical properties described.	leucyl-phenylalanine	100-107	brother of CDO	Oryctolagus cuniculus	90-93
8728025-5	1996	From the fact that the response to phorbol myristate acetate (PMA), as well as to formyl-methionyl-leucyl-phenylalanine (fMLP) was almost totally inhibited by superoxide dismutase (SOD), we conclude that O2.- is the reacting oxygen species measured.	leucyl-phenylalanine	98-119	formyl peptide receptor 1	Homo sapiens	121-125
2989297-1	1985	Stimulation of rabbit neutrophils by the chemotactic factors fMet-Leu-Phe and leukotriene B4, by platelet activating factor, or by arachidonic acid produces a rapid and dose-dependent increase in the amounts of actin and of a 65,000-mol-wt protein associated with the cytoskeleton.	leucyl-phenylalanine	66-73	actin	Oryctolagus cuniculus	211-216
3115599-7	1987	On the other hand, both the decrease in intracellular pH and the increase in cytoskeletal actin produced by fMet-Leu-Phe are inhibited by pertussis toxin treatment.	leucyl-phenylalanine	113-120	actin	Oryctolagus cuniculus	90-95
3532812-2	1986	Interleukin-1 (IL-1) was found to be several log times more potent in this respect than C5a des Arg, leukotriene B4, and f-Met-Leu-Phe and of comparable potency to endotoxin.	leucyl-phenylalanine	127-134	interleukin 1 alpha	Homo sapiens	0-13
3038127-3	1987	Auranofin, phenylbutazone, sulfasalazine and the phospholipase A2 inhibitor, 4-bromophenacyl bromide, strongly inhibited these responses in fMet-Leu-Phe stimulated cells, at concentrations below 50 microM.	leucyl-phenylalanine	145-152	phospholipase A2 group IB	Homo sapiens	49-65
31840993-3	2020	The utility of one-pot DSL-deselenization chemistry at phenylalanine and leucine was demonstrated through the rapid synthesis of a glycosylated interferon-gamma fragment and the chemokine-binding protein UL22A, respectively.	leucyl-phenylalanine	55-68	interferon gamma	Homo sapiens	144-160
6489-4	1976	The N-formyl, but not the amide derivative, of the leukotactic peptide Met-Leu-Phe was resistant to the action of CFI, as evidenced by chemotactic and biochemical assays.	leucyl-phenylalanine	75-82	complement factor I	Homo sapiens	114-117
31993977-1	2020	PURPOSE: Defective function of phenylalanine hydroxylase in phenylketonuria (PKU) results in the accumulation of phenylalanine (Phe) and the reduction of tyrosine (Tyr) in the blood, interfering in the normal development and function of organs and tissues in the body.	leucyl-phenylalanine	128-131	phenylalanine hydroxylase	Homo sapiens	31-56
31945513-0	2020	Renal and brain complications in GLA p.Phe113Leu Fabry disease.	leucyl-phenylalanine	39-48	galactosidase alpha	Homo sapiens	33-36
31945513-1	2020	Comments on "Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males" by Oliveira et al.	leucyl-phenylalanine	47-56	galactosidase alpha	Homo sapiens	41-44
32069268-4	2020	Here, we show that a single amino acid residue in CD28 drove T cell exhaustion and hindered the persistence of CD28-based CAR-T cells and substituting this asparagine to phenylalanine (CD28-YMFM) promoted durable anti-tumor control.	leucyl-phenylalanine	170-183	CD28 molecule	Homo sapiens	50-54
32069268-4	2020	Here, we show that a single amino acid residue in CD28 drove T cell exhaustion and hindered the persistence of CD28-based CAR-T cells and substituting this asparagine to phenylalanine (CD28-YMFM) promoted durable anti-tumor control.	leucyl-phenylalanine	170-183	CD28 molecule	Homo sapiens	111-115
32069268-4	2020	Here, we show that a single amino acid residue in CD28 drove T cell exhaustion and hindered the persistence of CD28-based CAR-T cells and substituting this asparagine to phenylalanine (CD28-YMFM) promoted durable anti-tumor control.	leucyl-phenylalanine	170-183	CD28 molecule	Homo sapiens	111-115
31909883-5	2020	More importantly, PIL-based ABSs exhibited unprecedented high partition coefficient for six bioactive compounds, tryptophan, phenylalanine, etc.	leucyl-phenylalanine	125-138	serpin family A member 2 (gene/pseudogene)	Homo sapiens	18-21
31678415-13	2020	KEGG pathway analysis showed that phenylalanine metabolism pathway and tyrosine metabolism pathway were greatly regulated by ACS treatment.	leucyl-phenylalanine	34-47	1-aminocyclopropane-1-carboxylate synthase homolog (inactive)	Homo sapiens	125-128
31871054-3	2020	Previously, we engineered a GAC protein (GAC(F327W)) in which a tryptophan residue is substituted for phenylalanine in an activation loop to explore the role of this loop in enzyme activity.	leucyl-phenylalanine	102-115	glutaminase	Homo sapiens	28-31
31899476-4	2020	Using computational, biochemical and biophysical tools, we delineated the role of all domains, their combinations and the critical phenylalanine residues in regulating HtrA3 activity, oligomerization and specificity.	leucyl-phenylalanine	131-144	HtrA serine peptidase 3	Homo sapiens	168-173
31758682-3	2020	OBJECTIVES: This study"s aim was to determine phenylalanine requirements (in the presence of excess tyrosine) during early and late gestation using direct amino acid oxidation (DAAO; with l-[1-13C]phenylalanine) and indicator amino acid oxidation (IAAO; with l-[1-13C]leucine).	leucyl-phenylalanine	46-59	D-amino acid oxidase	Homo sapiens	177-181
31871054-3	2020	Previously, we engineered a GAC protein (GAC(F327W)) in which a tryptophan residue is substituted for phenylalanine in an activation loop to explore the role of this loop in enzyme activity.	leucyl-phenylalanine	102-115	glutaminase	Homo sapiens	41-44
31978131-4	2020	The most common mutation in CFTR is a deletion of phenylalanine at position 508 (DeltaF508) in NBD1.	leucyl-phenylalanine	50-63	CF transmembrane conductance regulator	Homo sapiens	28-32
31993417-13	2019	Phenylalanine had the highest VIP score and was more abundant in the GF groups than in the PF groups.	leucyl-phenylalanine	0-13	vasoactive intestinal peptide	Homo sapiens	30-33
31993417-14	2019	Moreover, pathway and network analysis indicated that phenylalanine contributes to oxidoreductase and antioxidant reactions.	leucyl-phenylalanine	54-67	thioredoxin reductase 1	Homo sapiens	83-97
31936569-4	2020	The CatD substrate contained a phenylalanine-phenylalanine cleavage site more specific to CatD than BACE1.	leucyl-phenylalanine	31-58	cathepsin D	Homo sapiens	4-8
31936569-4	2020	The CatD substrate contained a phenylalanine-phenylalanine cleavage site more specific to CatD than BACE1.	leucyl-phenylalanine	31-58	cathepsin D	Homo sapiens	90-94
31936569-4	2020	The CatD substrate contained a phenylalanine-phenylalanine cleavage site more specific to CatD than BACE1.	leucyl-phenylalanine	31-58	beta-secretase 1	Homo sapiens	100-105
31782257-1	2020	Glutathione S-transferase Zeta 1-1(GSTZ1-1), an enzyme involved in the catabolism of phenylalanine and the detoxification of xenobiotics, plays a tumour suppressor role in hepatocellular carcinoma (HCC), but the underlying mechanism remains largely unknown.	leucyl-phenylalanine	85-98	glutathione S-transferase zeta 1	Homo sapiens	0-42
31885664-11	2019	NMR analysis also identified phenylalanine, an essential precursor for tyrosine that plays a role at the BDNF receptor.	leucyl-phenylalanine	29-42	brain derived neurotrophic factor	Mus musculus	105-109
31817162-1	2019	Chalcone isomerase (CHI) is a key component of phenylalanine metabolism that can produce a variety of flavonoids.	leucyl-phenylalanine	47-60	chalcone--flavanone isomerase	Gossypium hirsutum	0-18
31817162-1	2019	Chalcone isomerase (CHI) is a key component of phenylalanine metabolism that can produce a variety of flavonoids.	leucyl-phenylalanine	47-60	chalcone--flavanone isomerase	Gossypium hirsutum	20-23
31796073-11	2019	FCGR genotyping showed that patients who were homozygous for the Fc low-binding phenylalanine (F) allele for FCGR3A-158V/F were less likely to achieve pCR.	leucyl-phenylalanine	80-93	Fc gamma receptor IIa	Homo sapiens	0-4
31796073-11	2019	FCGR genotyping showed that patients who were homozygous for the Fc low-binding phenylalanine (F) allele for FCGR3A-158V/F were less likely to achieve pCR.	leucyl-phenylalanine	80-93	Fc gamma receptor IIIa	Homo sapiens	109-115
31885664-14	2019	The phenylalanine in SBH may have triggered the upregulation of BDNF genes in honey-treated mice and improved their spatial memory performance.	leucyl-phenylalanine	4-17	brain derived neurotrophic factor	Mus musculus	64-68
31666108-1	2019	BACKGROUND: Glutathione S-transferase zeta 1 (GSTZ1) is the penultimate enzyme in phenylalanine/tyrosine catabolism.	leucyl-phenylalanine	82-95	glutathione S-transferase zeta 1	Homo sapiens	12-44
31799428-2	2019	We found that the odorant binding protein OBP19b, which is highly expressed in Drosophila melanogaster taste sensilla, is necessary for the detection of several amino acids including the essential l-phenylalanine.	leucyl-phenylalanine	197-212	Odorant-binding protein 19b	Drosophila melanogaster	42-48
31799428-4	2019	Using a feeding-choice assay, we found that OBP19b is necessary for detecting l-phenylalanine and l-glutamine, but not l-alanine or D-phenylalanine.	leucyl-phenylalanine	78-93	Odorant-binding protein 19b	Drosophila melanogaster	44-50
31788587-3	2019	The crystal structure of SMYD3 in complex with MAP3K2 peptide reveals a shallow hydrophobic pocket (P-2), which accommodates the binding of a phenylalanine residue at the -2 position of the substrate (F258) is a crucial determinant of substrate specificity of SMYD3.	leucyl-phenylalanine	142-155	SET and MYND domain containing 3	Homo sapiens	25-30
31788587-3	2019	The crystal structure of SMYD3 in complex with MAP3K2 peptide reveals a shallow hydrophobic pocket (P-2), which accommodates the binding of a phenylalanine residue at the -2 position of the substrate (F258) is a crucial determinant of substrate specificity of SMYD3.	leucyl-phenylalanine	142-155	mitogen-activated protein kinase kinase kinase 2	Homo sapiens	47-53
31788587-3	2019	The crystal structure of SMYD3 in complex with MAP3K2 peptide reveals a shallow hydrophobic pocket (P-2), which accommodates the binding of a phenylalanine residue at the -2 position of the substrate (F258) is a crucial determinant of substrate specificity of SMYD3.	leucyl-phenylalanine	142-155	SET and MYND domain containing 3	Homo sapiens	260-265
31788587-6	2019	Furthermore, we investigated the structure-activity relationships (SAR) of a series of non-natural phenylalanine derivative substitutions at the -2 position and found that quite a few modifications on the sidechain of F258 residue could strengthen its binding to the P-2 pocket of SMYD3.	leucyl-phenylalanine	99-112	SET and MYND domain containing 3	Homo sapiens	281-286
31648944-1	2019	In phenylketonuria (PKU), mutations of the phenylalanine hydroxylase (PAH) gene decrease the ability of PAH to convert phenylalanine (Phe) to tyrosine (Tyr), resulting in Phe accumulation in the blood and brain and disruption of neurotransmitter (NT) biosynthesis and metabolism.	leucyl-phenylalanine	43-56	phenylalanine hydroxylase	Homo sapiens	70-73
31648944-1	2019	In phenylketonuria (PKU), mutations of the phenylalanine hydroxylase (PAH) gene decrease the ability of PAH to convert phenylalanine (Phe) to tyrosine (Tyr), resulting in Phe accumulation in the blood and brain and disruption of neurotransmitter (NT) biosynthesis and metabolism.	leucyl-phenylalanine	43-56	phenylalanine hydroxylase	Homo sapiens	104-107
31648944-1	2019	In phenylketonuria (PKU), mutations of the phenylalanine hydroxylase (PAH) gene decrease the ability of PAH to convert phenylalanine (Phe) to tyrosine (Tyr), resulting in Phe accumulation in the blood and brain and disruption of neurotransmitter (NT) biosynthesis and metabolism.	leucyl-phenylalanine	134-137	phenylalanine hydroxylase	Homo sapiens	43-68
31648944-1	2019	In phenylketonuria (PKU), mutations of the phenylalanine hydroxylase (PAH) gene decrease the ability of PAH to convert phenylalanine (Phe) to tyrosine (Tyr), resulting in Phe accumulation in the blood and brain and disruption of neurotransmitter (NT) biosynthesis and metabolism.	leucyl-phenylalanine	134-137	phenylalanine hydroxylase	Homo sapiens	70-73
31648944-1	2019	In phenylketonuria (PKU), mutations of the phenylalanine hydroxylase (PAH) gene decrease the ability of PAH to convert phenylalanine (Phe) to tyrosine (Tyr), resulting in Phe accumulation in the blood and brain and disruption of neurotransmitter (NT) biosynthesis and metabolism.	leucyl-phenylalanine	134-137	phenylalanine hydroxylase	Homo sapiens	104-107
31648944-1	2019	In phenylketonuria (PKU), mutations of the phenylalanine hydroxylase (PAH) gene decrease the ability of PAH to convert phenylalanine (Phe) to tyrosine (Tyr), resulting in Phe accumulation in the blood and brain and disruption of neurotransmitter (NT) biosynthesis and metabolism.	leucyl-phenylalanine	171-174	phenylalanine hydroxylase	Homo sapiens	43-68
31648944-1	2019	In phenylketonuria (PKU), mutations of the phenylalanine hydroxylase (PAH) gene decrease the ability of PAH to convert phenylalanine (Phe) to tyrosine (Tyr), resulting in Phe accumulation in the blood and brain and disruption of neurotransmitter (NT) biosynthesis and metabolism.	leucyl-phenylalanine	171-174	phenylalanine hydroxylase	Homo sapiens	70-73
31648944-1	2019	In phenylketonuria (PKU), mutations of the phenylalanine hydroxylase (PAH) gene decrease the ability of PAH to convert phenylalanine (Phe) to tyrosine (Tyr), resulting in Phe accumulation in the blood and brain and disruption of neurotransmitter (NT) biosynthesis and metabolism.	leucyl-phenylalanine	171-174	phenylalanine hydroxylase	Homo sapiens	104-107
31622584-4	2019	A phenylalanine in EapH2 replaces the leucine in EapH1 that sits over the hNE catalytic serine and creates a potential steric clash.	leucyl-phenylalanine	2-15	elastase, neutrophil expressed	Homo sapiens	74-77
31545012-5	2019	Here, we show that knock-in of phenylalanine to create VEGFR2 Y1212F in C57Bl/6 and FVB mouse strains leads to loss of growth factor receptor-bound protein 2- and phosphoinositide 3"-kinase (PI3K)p85 signaling.	leucyl-phenylalanine	31-44	kinase insert domain protein receptor	Mus musculus	55-61
31749908-3	2019	The deletion of phenylalanine at position 508 of the protein (F508del-CFTR) is the most common mutation observed in CF patients.	leucyl-phenylalanine	16-29	CF transmembrane conductance regulator	Homo sapiens	70-74
31666108-1	2019	BACKGROUND: Glutathione S-transferase zeta 1 (GSTZ1) is the penultimate enzyme in phenylalanine/tyrosine catabolism.	leucyl-phenylalanine	82-95	glutathione S-transferase zeta 1	Homo sapiens	46-51
31623189-5	2019	Plasma and brain phenylalanine concentrations tended to be lower in all FAH-/- mice.	leucyl-phenylalanine	17-30	fumarylacetoacetate hydrolase	Mus musculus	72-75
31541188-1	2019	Human phenylalanine hydroxylase (hPAH) hydroxylates L-phenylalanine (L-Phe) to L-tyrosine, a precursor for neurotransmitter biosynthesis.	leucyl-phenylalanine	39-67	phenylalanine hydroxylase	Homo sapiens	6-31
31636293-2	2019	Several halogen-containing L-phenylalanine-based ligands display high affinity and high selectivity for LAT1; nonetheless, their molecular mechanism of binding remains unclear.	leucyl-phenylalanine	27-42	solute carrier family 7 member 5	Homo sapiens	104-108
31541188-1	2019	Human phenylalanine hydroxylase (hPAH) hydroxylates L-phenylalanine (L-Phe) to L-tyrosine, a precursor for neurotransmitter biosynthesis.	leucyl-phenylalanine	39-67	phenylalanine hydroxylase	Homo sapiens	33-37
31807622-6	2019	Despite being rich in cysteine, the caprine KAP15-1 protein possesses a high content of serine and moderate content of glycine and phenylalanine.	leucyl-phenylalanine	131-144	keratin-associated protein 15-1	Capra hircus	44-51
31803461-0	2019	Pd-catalyzed site-selective C(sp2)-H radical acylation of phenylalanine containing peptides with aldehydes.	leucyl-phenylalanine	58-71	Sp2 transcription factor	Homo sapiens	28-33
31937997-2	2018	Novel compounds were generated as potential phenylalanine tRNA synthetase (PheRS) inhibitors based on the published homology model of S. aureus PheRS to aid the design process using Molecular Operating Environment (MOE) software.	leucyl-phenylalanine	44-57	phenylalanyl-tRNA synthetase subunit beta	Homo sapiens	75-80
30385721-6	2018	After 6 days, f-Met-Leu-Phe induced similar macrophage infiltration into the Matrigel plugs of WT and macrophage TGF-betaRII-/- mice, but TGF-beta induced infiltration only in WT mice.	leucyl-phenylalanine	19-27	transforming growth factor, beta 1	Mus musculus	113-121
31679193-1	2019	Interleukin 4 (IL4)-induced gene 1 (IL4I1) is an oxidase that degrades l-phenylalanine into phenylpyruvate, hydrogen peroxide, and ammonia.	leucyl-phenylalanine	71-86	interleukin 4	Mus musculus	0-13
31679193-1	2019	Interleukin 4 (IL4)-induced gene 1 (IL4I1) is an oxidase that degrades l-phenylalanine into phenylpyruvate, hydrogen peroxide, and ammonia.	leucyl-phenylalanine	71-86	interleukin 4	Mus musculus	15-18
31679193-1	2019	Interleukin 4 (IL4)-induced gene 1 (IL4I1) is an oxidase that degrades l-phenylalanine into phenylpyruvate, hydrogen peroxide, and ammonia.	leucyl-phenylalanine	71-86	interleukin 4 induced 1	Mus musculus	36-41
31937997-2	2018	Novel compounds were generated as potential phenylalanine tRNA synthetase (PheRS) inhibitors based on the published homology model of S. aureus PheRS to aid the design process using Molecular Operating Environment (MOE) software.	leucyl-phenylalanine	44-57	phenylalanyl-tRNA synthetase subunit beta	Homo sapiens	144-149